Pfizer Gets $1.95 Billion U.S. Deal For 100 Million Doses Of Planned Covid-19 VaccineForbes • 07/22/20
Pfizer, BioNTech Score $2 Billion Deal For Coronavirus Vaccine In U.S.Investors Business Daily • 07/22/20
Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2GlobeNewsWire • 07/22/20
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2Business Wire • 07/22/20
Could These Findings Dramatically Change the Opportunities for COVID-19 Vaccine Stocks?The Motley Fool • 07/22/20
What Does It Mean for Investors When a Coronavirus Vaccine Is "Fast-Tracked"?The Motley Fool • 07/21/20
U.K. Secures 30 Million Doses of Coronavirus Vaccine Candidate From Pfizer and BioNTechThe Motley Fool • 07/21/20
Coronavirus Vaccine Program From Pfizer and BioNTech Reports Preliminary SuccessThe Motley Fool • 07/20/20
BioNTech, Pfizer shares rally on preliminary data showing T-cell response from coronavirus vaccine candidateMarket Watch • 07/20/20
Pfizer-BioNTech Strike Deal With UK Government To Supply 30M Doses Of Coronavirus VaccineBenzinga • 07/20/20
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response DataGlobeNewsWire • 07/20/20
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaForbes • 07/20/20